STOCK PLUMMETS AFTER NOVO NORDISK DEAL COLLAPSE

Shares of HIMS experienced a dramatic slump today following the unexpected termination of its agreement with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending HIMS's stock price plummeting by over fifteen percent. The reason for the breakdown of the partnership remains unclear, but industry analysts speculate